Clinic of the Imaging Methods, University Hospital Plzen, Alej Svobody 80, Plzeň 304 60, Czech Republic.
Eur J Radiol. 2017 Sep;94:A1-A2. doi: 10.1016/j.ejrad.2017.05.004. Epub 2017 May 9.
The introduction of integrated PET/MRI imaging combining full magnetic resonance imaging and positron emission tomography is a new milestone in tissue imaging. As usual innovations in clinical practice generate new dilemmas. The questions it poses are: when to use PET/MRI scanning, what radiopharmaceutical to use and how to optimize examination protocols. A range of new radiopharmaceuticals, in addition to 18F-fluorodeoxyglucose (18F-FDG), are now available for assessing and characterizing tissues.
正电子发射断层扫描与磁共振成像相结合的一体化 PET/MRI 成像是组织成像的一个新的里程碑。与往常一样,临床实践中的创新带来了新的困境。它提出的问题是:何时使用 PET/MRI 扫描,使用哪种放射性药物以及如何优化检查方案。除了 18F-氟脱氧葡萄糖(18F-FDG)外,现在还有一系列新的放射性药物可用于评估和描述组织。